Effect of blockade of the renin-angiotensin and endothelin systems on rat tracheal allograft rejection

B. Antus, J. Fillinger, A. Sebe, C. Jeney, I. Horvath (Budapest, Hungary)

Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Session: Recent advances in clinical and experimental lung transplantation
Session type: Oral Presentation
Number: 3128
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Antus, J. Fillinger, A. Sebe, C. Jeney, I. Horvath (Budapest, Hungary). Effect of blockade of the renin-angiotensin and endothelin systems on rat tracheal allograft rejection. Eur Respir J 2007; 30: Suppl. 51, 3128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Tissular response of transplanted cryopreserved and lyophilized tracheal allograft treated with VEGF and immunosuppression in a canine model
Source: Eur Respir J 2005; 26: Suppl. 49, 177s
Year: 2005

Induction of tolerance to murine tracheal allograft by intrasplenic cytotransplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009

Targeted delivery of catalase to the pulmonary endothelium preserves graft function of non-heart-beating donor lungs in pigs
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008

Protection of vasoconstriction and lung function impairment by endothelin-receptor blockers and vasoactive intestinal peptide (VIP) in isolated perfused rat lungs
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007

Monitoring of liver function in patients with pulmonary hypertension treated with endothelin receptor antagonists: The value of a novel monitoring system
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010

Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 334s
Year: 2004

Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats
Source: Eur Respir J 2010; 35: 904-912
Year: 2010

Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005

Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005

Single centre experience with endothelin receptor blockade in pulmonary hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004

Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 739s
Year: 2006

Severe pulmonary hypertension in chronic lung disease. Long term effects on gas exchange of endothelin receptor antagonists or PDE5 inhibitors
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Dual endothelin receptor blockade: advances in pulmonary disease
Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience
Year: 2008

α1-adrenoceptor antagonism does not modify the pulmonary vasoconstrictor effect of dexfenfluramine in the rat
Source: Eur Respir J 2001; 18: Suppl. 33, 491s
Year: 2001

Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure
Source: Eur Respir J 2011; 37: 578-586
Year: 2011